FMC Corporation (FMC)
NYSE: FMC
· Real-Time Price · USD
33.62
0.47 (1.42%)
At close: Sep 26, 2025, 3:59 PM
33.86
0.71%
After-hours: Sep 26, 2025, 07:53 PM EDT
FMC Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fungicides Revenue | 80.4M | 52.7M | 122.8M | 84.8M | 74.5M | 70.4M | 88.8M | 55.5M | 72.3M | 101M | 136.6M | 75.3M | 63.3M | 108.7M | 77.1M | 63.4M | 94.5M | 90.5M | 71M | 59.4M | 61.8M | 83.3M | 81.4M | 61.3M | 58.2M | 70.5M |
| Fungicides Revenue Growth | +52.56% | -57.08% | +44.81% | +13.83% | +5.82% | -20.72% | +60.00% | -23.24% | -28.42% | -26.06% | +81.41% | +18.96% | -41.77% | +40.99% | +21.61% | -32.91% | +4.42% | +27.46% | +19.53% | -3.88% | -25.81% | +2.33% | +32.79% | +5.33% | -17.45% | n/a |
| Herbicides Revenue | 376M | 272.2M | 373.4M | 275.6M | 336.6M | 294.9M | 342.1M | 268M | 225.5M | 442.8M | 543.3M | 323.6M | 380.3M | 404.4M | 420.5M | 262.3M | 330.8M | 361.7M | 264.7M | 214.7M | 340.6M | 367.2M | 318.8M | 199M | 349.4M | 361.6M |
| Herbicides Revenue Growth | +38.13% | -27.10% | +35.49% | -18.12% | +14.14% | -13.80% | +27.65% | +18.85% | -49.07% | -18.50% | +67.89% | -14.91% | -5.96% | -3.83% | +60.31% | -20.71% | -8.54% | +36.65% | +23.29% | -36.96% | -7.24% | +15.18% | +60.20% | -43.05% | -3.37% | n/a |
| Insecticides Revenue | 525.3M | 402.7M | 659.6M | 647.9M | 569.1M | 501.3M | 651.4M | 582.4M | 658.9M | 746.7M | 810.5M | 872.3M | 897.1M | 766.7M | 798.9M | 792.3M | 741.8M | 687M | 689.7M | 746.8M | 679.9M | 720.4M | 710.2M | 649.7M | 710.3M | 703.4M |
| Insecticides Revenue Growth | +30.44% | -38.95% | +1.81% | +13.85% | +13.52% | -23.04% | +11.85% | -11.61% | -11.76% | -7.87% | -7.08% | -2.76% | +17.01% | -4.03% | +0.83% | +6.81% | +7.98% | -0.39% | -7.65% | +9.84% | -5.62% | +1.44% | +9.31% | -8.53% | +0.98% | n/a |
| Plant Health Revenue | 44.9M | 45.2M | 64.9M | 47.3M | 43.5M | 44.8M | 48.6M | 42.6M | 43.4M | 52.3M | 64.8M | 53.2M | 62.7M | 53.4M | 61M | 53.5M | 52.1M | 50.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Plant Health Revenue Growth | -0.66% | -30.35% | +37.21% | +8.74% | -2.90% | -7.82% | +14.08% | -1.84% | -17.02% | -19.29% | +21.80% | -15.15% | +17.42% | -12.46% | +14.02% | +2.69% | +3.78% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 158.8M | 125.4M | 306.6M | 186.5M | 191.2M | 164.1M | 278.4M | 207.2M | 265.7M | 230.4M | 278.1M | 288.2M | 375.4M | 296.9M | 277.7M | 305.9M | 379M | 292M | 287.5M | 254.6M | 316.8M | 247.9M | 258.9M | 219.4M | 311.6M | 255.3M | 1.05B | 252M |
| Asia Pacific Revenue Growth | +26.63% | -59.10% | +64.40% | -2.46% | +16.51% | -41.06% | +34.36% | -22.02% | +15.32% | -17.15% | -3.50% | -23.23% | +26.44% | +6.91% | -9.22% | -19.29% | +29.79% | +1.57% | +12.92% | -19.63% | +27.79% | -4.25% | +18.00% | -29.59% | +22.05% | -75.64% | +315.87% | n/a |
| Emea Revenue | 260.4M | 272.8M | 187.5M | 139.3M | 201.2M | 306.8M | 159.6M | 149M | 207.6M | 383M | 210M | 150.7M | 280.8M | 398.2M | 196.3M | 171.4M | 272.9M | 399.4M | 212.8M | 152.8M | 265.4M | 415.3M | 147.1M | 138.4M | 304.3M | 412M | 641.7M | 398.8M |
| Emea Revenue Growth | -4.55% | +45.49% | +34.60% | -30.77% | -34.42% | +92.23% | +7.11% | -28.23% | -45.80% | +82.38% | +39.35% | -46.33% | -29.48% | +102.85% | +14.53% | -37.19% | -31.67% | +87.69% | +39.27% | -42.43% | -36.09% | +182.32% | +6.29% | -54.52% | -26.14% | -35.80% | +60.91% | n/a |
| Latin America Revenue | 310.4M | 206.8M | 390.2M | 504.1M | 307.2M | 188M | 432.7M | 466.1M | 268.7M | 233.6M | 693.7M | 697.1M | 431.5M | 265.9M | 613.7M | 516.9M | 299.6M | 203.2M | 471.2M | 464.9M | 261.2M | 259.2M | 518.3M | 460.2M | 256.7M | 206.5M | 1.05B | 158.9M |
| Latin America Revenue Growth | +50.10% | -47.00% | -22.59% | +64.10% | +63.40% | -56.55% | -7.17% | +73.46% | +15.03% | -66.33% | -0.49% | +61.55% | +62.28% | -56.67% | +18.73% | +72.53% | +47.44% | -56.88% | +1.36% | +77.99% | +0.77% | -49.99% | +12.62% | +79.28% | +24.31% | -80.39% | +562.81% | n/a |
| North America Revenue | 320.9M | 186.4M | 340M | 235.5M | 338.8M | 259.1M | 275.4M | 159.6M | 272.5M | 497.3M | 440.2M | 241.2M | 364.6M | 389.8M | 325.9M | 199.8M | 290.5M | 301M | 180.7M | 212.3M | 311.9M | 327.6M | 273M | 196.3M | 333.5M | 318.3M | 877M | 298.2M |
| North America Revenue Growth | +72.16% | -45.18% | +44.37% | -30.49% | +30.76% | -5.92% | +72.56% | -41.43% | -45.20% | +12.97% | +82.50% | -33.85% | -6.46% | +19.61% | +63.11% | -31.22% | -3.49% | +66.57% | -14.88% | -31.93% | -4.79% | +20.00% | +39.07% | -41.14% | +4.78% | -63.71% | +194.10% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 176.8M | 172M | 156.7M | 159.2M | 164.9M | 164M | 171.5M | 171.3M | 205.6M | 190.5M | 212.5M | 179.4M | 194.8M | 188.5M | 195.1M | 183.5M | 161M | 174.5M | 181.6M | 187.7M | 171M | 189.4M | 223.8M | 188.3M | 196.9M | 183.9M | 202.6M | 207.6M | 211.4M | 200.4M | 231.6M | 150.9M | 126.4M | 109.7M | 156.1M | 117.8M | 129.1M | 126.5M | 147M | 137M | 156M | 297.9M |
| Selling, General, and Administrative Revenue Growth | +2.79% | +9.76% | -1.57% | -3.46% | +0.55% | -4.37% | +0.12% | -16.68% | +7.93% | -10.35% | +18.45% | -7.91% | +3.34% | -3.38% | +6.32% | +13.98% | -7.74% | -3.91% | -3.25% | +9.77% | -9.71% | -15.37% | +18.85% | -4.37% | +7.07% | -9.23% | -2.41% | -1.80% | +5.49% | -13.47% | +53.48% | +19.38% | +15.22% | -29.72% | +32.51% | -8.75% | +2.06% | -13.95% | +7.30% | -12.18% | -47.63% | n/a |
| Research and Development Revenue | 66.4M | 68.7M | 72.2M | 69M | 75.9M | 60.9M | 81.8M | 80.9M | 87.7M | 78.4M | 84.4M | 78.5M | 79.5M | 71.8M | 85.3M | 79.5M | 65.9M | 74M | 84.6M | 71.7M | 64.3M | 67.3M | 76.4M | 77.4M | 73.1M | 71.2M | 76.8M | 70.9M | 77M | 65.9M | 51.1M | 30.2M | 32M | 28.2M | 38.2M | 32.2M | 35.1M | 36M | 40.9M | 37.2M | 39M | 26.6M |
| Research and Development Revenue Growth | -3.35% | -4.85% | +4.64% | -9.09% | +24.63% | -25.55% | +1.11% | -7.75% | +11.86% | -7.11% | +7.52% | -1.26% | +10.72% | -15.83% | +7.30% | +20.64% | -10.95% | -12.53% | +17.99% | +11.51% | -4.46% | -11.91% | -1.29% | +5.88% | +2.67% | -7.29% | +8.32% | -7.92% | +16.84% | +28.96% | +69.21% | -5.62% | +13.48% | -26.18% | +18.63% | -8.26% | -2.50% | -11.98% | +9.95% | -4.62% | +46.62% | n/a |